Adicet Bio, Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was USD 24.99 million compared to negative sales of USD 3.98 million a year ago. Net income was USD 4.62 million compared to net loss of USD 21.32 million a year ago. Basic earnings per share from continuing operations was USD 0.12 compared to basic loss per share from continuing operations of USD 0.82 a year ago. Diluted earnings per share from continuing operations was USD 0.1 compared to diluted loss per share from continuing operations of USD 0.82 a year ago.